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ABSTRACT
The lymphocytic family of cells is very sensitive to radiation. The
basic reasons for employing radiation as an immunosuppressive agent are to
destroy existing lymphocytes as well as to suppress production of new cells
and thereby interfere with their role in inmunological reactions. In view
of the difficulties in the clinical application of lethal and sublethal
whole body irradiation for immunosuppression, investigators have attempted
a variety of techniques to radiate selectively immunocompetent lymphocytes.
The observation that many lymphocytes recirculate from blood to lymph and
back to blood has provided one basic lead in the development of these
techniques. This unique physiological phenomenon of lymphocyte recirculation
enables one to deplete many of immunocompetent, recirculating lymphocytes by
radiation without producing harmful effects to body at large.
Techniques that have been explored for selective immunosuppression
by radiation include the following; (1) Surface radiation applicators for
individual lymphoid organs such as the spleen and the appendix; (2) Radia-
tion of individual lymphoid organs such as the thymus and the spleen; (3)
Radiation of allografts either in the immediate post-transplant period or
during the rejection episodes; (4) Indwelling intravascular radiation
sources; (S) Intravascular or intralymphatic injections of radioisotopes
and; (6) Extracorporeal irradiation of blood, central lymph and regional
efferent lymph.
The historical aspects of selective lymphocyte radiation are
reviewed as well as the problems concerned with dosimetry and the
radiosensitivity of circulating blood elements other than lymphocytes.
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Thc posBibil iticH of perturbations in steady Btc-.c lymphocytopoicsis
which might bo triggered by products of radiation induced cell death
are presented, however the parameters investigated thus far, such as
the degree cf lymphocytopenia, thoracic duct lymphocyte output and
cell cycle times of thoracic duct lymphocytes, have failed to reveal
any such perturbations. Studies in adrenalectomized calves have
failed to confirm the notion that lymphocytopenia following extracorporeal
irradiation of blood and lymph might primarily be accounted for by
stress induced corticosteroid hormonal activity.
Of the various techniques enumerated above only local graft
irradiation and extracorporeal irradiation of blood have found clinical
application. The results obtained have been encouraging and indicate
a need for additional, well-controlled clinical trials, especially with
regard to the role of ECIB as an adjunct to standard immunosuppressive
therapy. The experimental results with extracorporeal irradiation of
lymph have also established the potential of this technique for clinical
application.
There is an urgent need for studying the influence of irradiation
on various subpopulations of lymphocytes with regard to their functional
capabilities and in particular with regard to their reproductive potential.
Possible influence of selective blood irradiation on circulating stem
cells in blood needs to be evaluated.
INTRODUCTION
The extreme sensitivity of the lymphocyte to radiation end the
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intimate involvement of this cell in immunological reactions have
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been adequately discussed during the previous sessions of this symposium.
With whole body radiation (WBR), one is faced with injury to all prolif-
erating cell systems, free circulating cells, as well as the disturbance
of the interrelationship between organ systems. Biologic responses of
WBR are thus extremely complicated and it is difficult to sort out the
various facets of importance . WBR does indeed lead to a state of immuno-
suppression consequent upon lymphocyte depletion , but as noted above,
this approach suffers from a lack of selectivity. Furthermore, lympho-
g
cyte subpopulations exhibit different degrees of radiosensitivity
and radiation induced immunosuppression has been shown to be dependent
9
upon dose rate and radiation quality . Various approaches for radiation-
induced selective immunosuppression have previously been reviewed • The
present review will be limited primarily to a discussion of the extra-
corporeal irradiation of blood, central lymph, and regional lymph, as
techniques for selective immunosuppression.
It was demonstrated by Gowans that a fraction of lymphocytes
recalculate from blood to lymph and back to blood . Gowans and Knight
further demonstrated that the post-capillary venules in lymph nodes and
other lymphoreticular tissues are the major sites for the exit of
lymphocytes from the blood . Lymphocyte recireulation through peripheral
lymphoid tissues was directly demonstrated by the studies of Cronkite
12
et al . Ford has described in detail lymphocyte recirculation within
13
the spleen . The underlying principles for extracorporeal irradiation
of blood (ECIB) and lymph (ECIL) are to utilize the extreme sensitivity
of lymphocytes to radiation and, by virtue of the traffic patterns of
blood and lymph lymphocytes, to induce not only lymphocytopenia in the
blood arid lymph but also to deplete lymphocytes in the lymphoreticular
organs.
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EXTOACORPOREAL IRRADIATION: HISTORICAL ASPECTS
Before discussing the current status of ECIB and ECIL, it is
appropriate to describe briefly the early attempts at physical treat-
ment of circulating blood outside of the body, an experimental proce-
14
dure first developed by Heymans in 1921 . Similar techniques were
subsequently used by Da11'Aqua and Zoppellari and by Ducuing et al
Due to technical difficulties, these investigators were unable to
deliver an adequate dose of radiation to the circulating blood. In
1958, Arnould et al reported ECIB in the anesthetized rat . They
observed the development of anemia and leukopenia. Pellerin et al
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studied further the development of anemia and leukopenia and found
that leukopenia was predominantly due to an initial depression in the
blood lymphocytes. There is no indication in any of these early
reports of efforts to suppress immunity by extracorporeal irradiation.
In this context it is worth pointing out that as early as 1914 Murphy
at the Rockefeller Institute had attempted to modify the rejection of
19
a tumor transplant by interference of lymphocyte function by radiation
In 1962, Lajtha et al discussed the therapeutic potential of ECIB in
leukemia and also indicated that destruction of a long-lived circulating
20
cell population in the normal blood might influence the immune response
EXTRACORPOREAL IRRADIATION: TECHNICAL, PHYSIOLOGICAL AND RADIOBTOLOGICAL
ASPECTS
At Brookhaven, ECIB and ECIL were developed initially to deplete
whole body lymphocytes and study the regulation of lymphocyte production
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analogous to hemorrhage for study of erythropoiesis ' ' . During the
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devclopment of ECIB and ECIL knowledge on lymphocytes grew at a rapid
pace and there arc now numerous areas under investigation. For ECIB,
carotid-jugular shunts are employed in large animals (Fig. 1). The
arterial blood traverses the radiation field before returning via the
vein. In patients, shunts are similar to radial artery-cephalic vein
shunts as employed for hemodialysis. For ECIL, thoracic duct-jugular
vein shunts are employed. The technical aspects of large animal and
23 24
human shunts have been published '
Radiation Sources and Dosimetry
20 25-29
Various types of radiation sources have been described ' . In
addition, ordinary x-ray sources and conventional cobalt therapy units
have also been employed for extracorporeal irradiation. For the calculation
of the radiation dose by the blood during ECIB, both "differential equation"
and "exact probability" models have been utilized ~". The radiation dose
received by a cell during one circuit past the radiation source is referred
to as the transit dose. The transit dose can be calculated from the follow-
ing formula:
D = | X R
D = transit dose
V = the volume of external shunt in litres
F = the flow rate in the external shunt in litres/min.
R = the dose rate for the irradiator in rads/min.
The range in residence time of cells and molecules within the blood
varies from seconds to an average of four months for erythrocytes. One
can estimate the dose distribution only to those entities that remain in
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thc blood for a period longer than the session of ECIB. For practical
purposes this applies to erythrocytes and platelets. The granulocyte
leaver the blood randomly with an average sojourn of 9.5 hours and
does not return to the blood thus the radiation dose will be only a
small multiple of' the transit dose. Lymphocytes are in part recycling
from the blood to the lymphoid tissues . In this case it is exceedingly
difficult to ascertain the dose distribution to the cells. Since the
statistics of recycling of lymphocytes are unknown It is assumed that
the minimum dose is the transit dose. For this reason, and from the
work of Trowell , a transit dose of 900 rads was selected for the
initial studies because it was thought that 90% of the lymphocytes
would be killed by one transit. The accumulation of radiation dose
by erythrocytes and platelets does not create any great difficulty in
planning ECIB schedules since they are relatively radioresistant
Schnappauf et al have shown that radiosensitivity of bovine erythrocytes
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increases with erythrocyte age . For prolonged irradiation or
intermittent irradiation extending for weeks or months, one should
not only consider the daily replacement of erythrocytes by newly
formed, relatively radioresistant cells but also the influence of
accumulated dose of radiation upon erythrocyte life span.
Schedules of ECIB/ECIL and Transit Dose
The ideal situation would be a schedule of extracorporeal irradiation
during which all circulating lymphocytes received a lethal dose of
radiation. It soon became apparent that with a transit dose cf
900 rads and prolonged ECIB, severe hemolysis resulted from
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cucnulativc radiation injury to erythrocytes. Accordingly, the influence
»
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of varying transit doses was investigated . Transit doses as low as 15
rads produced lymphocytopenia but of lesser degree than attained at higher
transit doses. Compared to continuous ECIB, repetitive short sessions
would appear to be more efficient in producing lymphocytopenia and much
safer, since the probability of inducing hemolysis by radiation injury
to the erythrocytes is diminished. Increased efficiency of repetitive
ECIB probably results from the establishment of new equilibria between
tissue and blood lymphocyte pools between ECIB sessions. When time is
allowed to irradiate 5 blood volumes nearly 100% of the lymphocytes in
the blood at commencement of the treatment will have received one
transit dose. As shown in Figure 2, continuation of ECIB sessions
beyond the time required to irradiate the equivalent of 5 blood volumes,
increases the radiation damage to erythrocytes without significantly
increasing the proportion of lymphocytes irradiated. Because of these
considerations, an average transit dose of ~ 500 rads with daily
repetitive sessions of ECIB has beer. used. In Figure 3, the range
of transit dose is superimposed on Trowell's data for the in-vivo
radiosensitivity of lymphocytes.
Since the LD __ for the cells of interest, the average time spent
in the blood, the rate of recycling from blood to lymphoreticular
tissues and the average time needed to remove fatally injured cells
are not known, it is not possible to define the ideal ECIB schedule.
The situation is further complicated by the heterogeneity of lymphocytes
with regard to thel'r radiosensitivity, traffic patterns and
life span in circulation. The difficulty
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is compounded by the fact that thymus-derived cells arc intimately involved
in immune reactivity, constitute a major fraction of the recycling pool,
and are also a major fraction of the newly produced cells in the
circulating blood. The latter fraction is short lived and not a part
41
of the recycling pool . Little information concerning the effects of
ECIB on various subpopulations of blood lymphocytes such as 'B' and 'T'
cells is available. In a preliminary study, no change was observed in
42
PHA response during ECIB .
With ECIL any transit dose can be given since one is not concerned
with cumulative damage to erythrocytes. With continuous ECIL transit
doses around 1000 rads have been used (Fig. 3). Figure 4 shows the
influence of low and high transit dose on thoracic duct lymphocyte
output. It is evident that the high transit dose is more effective in
reducing the output of thoracic duct lymphocytes.
Another reason for utilizing a higher transit dose is to reduce
the fraction of cells surviving with "mutations". The radiosensitivity
Q
of the lymphocytes and the immune response have been reviewed . In
summary, the conclusions of this review indicate that: (i) Radio-
sensitivity of cells cannot be estimated by the measurement of the
radioresistant phenomena such as DNA and enzyme synthesis, enzyme
function and antibody synthesis, (ii) There seems to be no difference
in response of newly-formed H-thymidine labeled lymphocytes versus older
lymphocytes to a single dose of x-ray, (ill) Proliferating lymphocytes
have about the same radiosensitivity as other cell renewal systems
as far as reproductive integrity is concerned, (iv) The only meaningful
parameter for radiosensitivity of lymphocytes involved in immune reactions
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is the suppression of the reproductive capability.
Lymphocyte Depletion by EC1B/ECIL
ECIB and ECIL produce both a marked blood lymphocytopenia
as well as a substantial reduction in the output of thoracic duct
, . 7.12,20-22,30,40,43-52 , .,,.., r ui J
lymphocytes . Lymphocyte depletion of blood
and lymph follows a curve with at least two components. The first
component has a half time of 1.2 days and corresponds to the
elimination of an easily mobilizable pool of lymphocytes. The
second component has a half time of approximately 30 days and
corresponds to a more sessile mass of lymphocytes. Calculations
based on this data, indicate the size of the easily mobilizable
pool to be approximately 10 times the number of circulating blood
9 53
lymphocytes, or 3-5 x 10 lymphocytes/Kg body weight . In untreated
calves the volume distribution of thoracic duct lymphocytes is a
3
continuum between 120 and 1200 |i , however, within this range there
are two overlapping populations of cells; a smaller population with
a median of 250 H , and a larger population with a median of 648 |A \
Lymphocytopenia induced by extracorporeal irradiation markedly alters
the size distribution due principally to a loss of cells within the
smaller lymphocyte category"* .
Cottier et al and Ruchti et al have reported on the depletion of
lymphoreticular tissues by ECIB "" . Briefly, the thymic cortex is
diminished in thickness with a decreased corticomedullary ratio.
Splenic lymph follicles are markedly reduced in size as a result of
loss of small lymphocytes from the cuffs surrounding germinal centers.
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There is also a loss of lymphocytes from Che less densely populated areas
«
of the white pulp and from the red pulp. There Is a striking loss of
lymphocytes from the paracortical areas of the lymph nodes. Disintegrating
cells are found in intrafollicular zones of the cortex or near the cortico-
medullary junction. Germinal centers in the spleen and lymph nodes are
intact and appear to have increased mitotic activity. A considerable
proportion (~ 85%) of the lymphoid cells of cortical zone of lymph
nodes is sessile while the paracortical areas of lymph nodes and the
white pulp of the spleen contain a larger fraction of easily mobilizable
lymphocytes (~ 50%) 5 8.
Influence of ECIB/ECIL on Mechanisms Regulating Lymphocytopoiesis!
The noticr that the lymphocytes are highly radiosensitive is due
to the rapid disappearance of advanced morphological damage in lymphoid
organs following irradiation that produces interphase death of the
lymphocytes. Extracorporeal irradiation kills circulating radiosensitive
lymphocytes which are then cleared by the lymphoreticular system with
presumably little harm to the other cell systems . The effect of the
products of lymphocyte death on steady-state lymphocytopoiesis is,
however, not known. In a series of experiments, two approaches were
utilized in an effort to gain some information pertaining to this
59
problem . In the first approach, removal of cells from the thoracic
duct lymph were compared to those obtained by ECIL. It has been
suggested, that under normal conditions, large numbers of lymphocytes
are lost from the body via the Intestinal tract . In the second
approach the loss of lymphocytes via a thoracic duct-rumen fistulae
was compared to ECIL. There were no significant differences in the
degree of lymphocytopenia and/or the output of lymphocytes in the
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thoracic duct between ECIL, continuous centrifugation of lymph, or •
thoracic duct-rumen fistulae.
In another series of experiments, cell cycle times of bovine
thoracic duct lymphocytes were measured before and following extra-
corporeal irradiation. The duration of the various phases of cell
cycle was measured by methods of mitotic labeling index and the
decrease in mean grain count of labeled mitotic figures . The cell
cycle phases were not affected by ECIB . Moreover, there was no
discernible increase in the mitotic figures with chromosomal
abnormalities. From these observations, it was concluded that
lymphocytes passing through the irradiation field were injured to
such an extent that they ware unable to home on the lymph r._-les,
proliferate and return to thoracic duct.
In another study, cell cycle parameters were measured by the
analysis of labeled mitosis and double labeling before and after
62
BCIL . ECU. had no detectible effect on either the duration of
cell cycle phases or the fractional production rate of lymphocytes.
Studies of Chan and Hayhoe have suggested that in patients with
leukemia, ECIB may alter the feedback mechanisms of growth control
resulting in increased proliferation of the leukemic blast cell.
There is, however, no information available with regard to similar
changes in normal steady state hemopoiesis.
Studies in mice , guinea pigs and dogs have shown hemopoietic
stem cells to be present in the circulating blood. Yoffey has suggested
that small lymphocytes enter the peripheral blood via lymphatics and
then seed the bone marrow where they function as hemopoietic stem cells
68 69 70
Attempts in mice , rats and dogs to test this hypothesis have
provided contradictory results. The majority of the evidence, however,
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does not: support Yoffey's notion. On the other hand, it has been suggested
that hemopoietic stem cell may be morphologically similar to small lympho-
cytes . In view of the presence of circulating stem cells in the blood
and the relative radiosensitivity of these cells , it is logical to ask
the question as to whether ECIB affects these stem cells? No data are
available that bear on this subject.
Influence of Corticosteroids en ECIB/ECIL Induced Lymphocytopenia
The cytolytic action of corticostef.oid hormones on lymphoid tissues
72
is well recognized . Surgical and experimental manipulations associated
with ECIB/ECIL are stressful procedures resulting in increased endogenous
corticosteroid production. It is, therefore, important to establish that
blood lymphocytopenia, decreased thoracic duct lymphocyte output and
lymphoid tissue depletion are primarily the result of radiation injury
rather than increased corticosteroid secretion. Corticosteroid hormones
primarily affect the germinal centers as compared to other areas of the
lymph nodes, and in addition spare the lymphocytes in the marginal zone
of follicles . In studies of the lymphoid tissue following ECIB, depletion
of germinal centers was not observed * . In contrast Storb et al observed
germinal center atrophy following ECIB in the baboon most probably
attributable to stress induced corticosteroid secretion due to prolonged
retention of the experimental animals in restraining chairs.
In order to further clarify this issue, additional studies have
been carried out in 10 calves. Five calves were bilaterally adrenalectomized
at the age of 4 weeks and maintained on hydrocortisone acetate and
deoxycorticosteroid. The remaining group of 5 calves was subjected to
fl... A J. ., Hi... _<
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sham adrcnalcctomy and given no cortlcostcroids. Two to 3 weeks »
following surgery A animals (2 adrenalectomized, 2 sham-adrenalecto-
mized) were subjected to 10 daily sessions of ECIB each (5 blood
volumes/session at a transit dose of 800 rads). Two calves (1 adrenal-
ectomized and 1 sham-adrenalectomized) were submitted to 10 days of
continuous ECIL. Four animals served as non-treated controls.
The results are shown in Figures 5 and 6. The drop in blood
lymphocyte counts was similar in adrenalectomized and sham-adrenal-
ectomized calves. The minor differences observed in adrenalectomized
and sham-adrenalectomized calves following ECIB, were slight and
within the variation observed in other calves previously subjected
to ECIB. The histological examination of lymphoid tissues has not
been completed. We conclude from these data that under the experimental
conditions employed in our laboratory, ECIB/ECIL-induced lymphocytopenia
is primarily the result of radiation injury to circulating lymphocytes
and is not mediated via corticosteroid hormones.
SELECTIVE IMMUNO-SUPPRESSION BY RADIATION
Techniques Other Than Whole Body Irradiation
In examining these p.visibilities, one must consider the relationship
of the lymphocytes to immune reactions. Central and peripheral sensitization
theories have been advanced with respect to the initial reaction of lympho-
cytes to foreign antigen. The end result, however, is the same i.e.,
production of specific responsive cells which are committed either to react
against an allograft or to the production of specific antibodies. These
specific cells, initially generated in the regional lymph nodes, migrate
-15-
to the distant lymphoid organs via the efferent lymphatics and blood ,
thereby amplifying the immune response. There are several approaches
by which one can interrupt the sequence of events through modes of
radiation other than whole body exposure. Most of these approaches
have been investigated and have been reviewed in detail . Briefly,
they include: (i) Irradiation of the arterial blood to an allograft.
(ii) Irradiation of the recipient bed prior to transplantation, (iii)
Irradiation of the reticulo-endothelial system through radioactive
colloids or other radioisotopes. (iv) Irradiation of lymphoid organ; such
as the thymus, spleen and regional lymph nodes, (v) Irradiation of
blood by intravascular radioactive sources, (vi) Irradiation of
transplanted organs. (vii) Extracorporeal irradiation of blood and lymph.
The last two approaches are the only approaches that have shown any
potential for clinical application. Local graft radiation has been
reviewed previously . This technique has been used clinically in
transplantation of the kidney, liver and heart. It is used sequentially
in the early transplant period and during periods of accelerated rejection.
This technique has proven to be of some effectiveness as a clinical and
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experimental immunosuppressive agent '
With reference to techniques other than extracorporeal irradiation,
certain investigations reported subsequent to the previous review ,
merit some discussion. Ford demonstrated that chronic irradiation of
32
the rat spleen by a P-impregnated polyethelene strip applied to
the antihilar surface produced a decrease in the numbers of circulating
small lymphocytes and a considerable reduction in the output of thoracic
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duct cells . Yoshida ct al investigated the immunosupprcssive
potential of this technique and demonstrated a significant depression
of both cellular and humoral immune responses . Moderate lymphopenia
32
was observed in rabbits when P strips were applied to the appendix
78
but the immune response of these rabbits was not detectably impaired
This later study did, however, confirm the existence of lymphocyte
recirculation through the appendix, a finding which is inconsistent
79
with the notion of rabbit appendix being a central lymphoid organ
Near-lethal dose of WBR are effective in suppressing cellular and
80
humoral immune responses . Single, relatively massive doses of
radiation given to the regional lymph node just prior to antigenic
81
stimulation, however, do not suppress immunological responsiveness ,
o
although the immuncompetent lymphocytes are highly radiosensitive .
This failure has been explained by the repopulation of the lymph node
82
by blood born lymphocytes . In principle, repeated local irradiation
of the regional lymph node following antigenic stimulation might be
more effective than a single large dose. Eltringham and Weissman have
conducted such studies in rats and have demonstrated a marked suppression
of the induction of delayed hypersens itivity and humoral antibody
formation following antigenic stimulation with sheep erythrocytes
-17-
The immunosupprcssive potential of various parenterally
administered radioisotopes was previously reviewed . Roser and
Ford have since published studies concerning intrasplenic or
intra nodal isotope injection . Intrasplenic injection of W-
tungsten trioxide resulted in a deficit of blood and thoracic duct
lymphocytes. Ihis lymphocytopenia persisted for weeks. The primary
immune responses to sheep erythrocytes and S. adelaid flagella antigens
were depressed, however, secondary responses to flagella were unaffected.
With regard to allograft rejection, skin graft survival across a weak
histocompatibility barrier was prolonged, however, no prolongation of
skin graft survival was observed when crossing strong histocompatibility
barrier. This difference was attributed to the presence of a much higher
proportion of lymphocytes reactive to strong histocompatibility antigens.
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Similar results had earlier been obtained by McGregor and Gowans
These investigators produced lymphocytopenia by chronic drainage of
185
the rat thoracic duct lymph. Intrasplenic W-tungsten trioxide
has been shown to be an effective immunosuppressive technique, but
as the authors point out, its clinical potential is limited by
the risk of inducing neoplasia.
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Extracorporeal Irradiation of Blood ,
Experimental Studies
Cauchi and Field have utilized ECIB to study the kinetics and
radiosensitivity of immunologically competent cells in the blood
In these studies, the survival of irradiated circulating cells was
assessed in syngeneic rats of a parental strain by splenomegaly induced
by cross circulation with F] hybrids. ECIB of the donor was carried
out either during cross-circulation or at various time intervals prior
to cross-circulation. Influence of ECIB on immunocompetent cells was
measured by reduction in GVH - inducing capacity as assayed by
changes in recipient spleen weight; The results of these studies
suggest the presence of two populations of immunocompetent cells in the
blood, both capable of inducing GVH reactions. One population is
6 times as radioresistant as cells in lymphoid organs and has a
turnover time of 5 hours; the second population shows the usual
radiosensitivity of the lymphoid tissues and restores GVH-inducing
capacity to the blood within an hour after this capacity has been
destroyed by ECIB. These studies clearly demonstrate the ability
of ECIB to deplete the blood of cells participating in cellular
immune reactions.
The results of studies concerning the influence of ECIB on
bovine skin allograft rejection have been described in a series
49 59 87-90
of papers ' ' . Various schedules of ECIB and combinations
of ECIB, chemotherapy and thymectoray were employed in these studies.
Continuous ECIB for 24 hours a~ transit doses of 15 to 60 rads,
five days prior to skin grafting, did not prolong skin allograft
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survival. Rep fitlve pregraft ECIB at transit doses of 50 to 1000 rails
for a total radiation time of 98 to 114 hours, prolonged the graft
survival time by 2 to 3 days and suppressed the intensity of the
rejection process. Repetitive pre- and postgraft ECIB was the most
effective in prolonging skin allograft survival particularly when
used in combination with small doses of azathioprine, which by
themselves were ineffective in altering the allograft rejection time.
These results suggest that ECIB and immunosuppressive drugs may be
synergistic and the combined use might permit one to decrease the
dose of chemotherapeutic agents without loss of immunosuppressive
potential.
Calves were thymectomized at 56 to 205 days of age. The interval
between ECIB and thymectomy ranged from 2 to 205 days of age. ECIB
schedules consisted of pre- and postgraft repetitive exposures. The
results of these studies demonstrated that the combination of
thymectomy and ECIB was no more effective in prolonging skin allograft
than ECIB alone. These data do not support the notion that thymectomy
is a beneficial part of an immunosuppressive regime in organ
transplantat ion.
The effectiveness of ECIB is limited by: (a) ECIB "kills" only
that fraction of immunocimpetent cells which are diverted thru the
irradiator and (h) ECIB can only be carried out with high transit
doses for only a few hours each day due to accumulation of radiation
36 39 •
damage to erythrocytcs '
Storb et al have studied on the influence of continuous ECIB
on skin allograft survival in baboons. Due to excessive dose delivered
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to the crythrocytcs, the experimental animals developed severe hemolytic
anemia. ECIB resulted in prolonged, severe lymphocytopenia and a
significant prolongation of skin allograft survival. Despite germinal
center atrophy in these animals there was no depression of antibody
formation against sheep erythrocytes. The effects of ECIB on primary
and secondary responses to tetanus toxoid have been studied. ECIB
failed to abolish antitoxin responses to sucutaneous immunization
91 92
with either fluid or aluminum phosphate-absorbed tetanus toxoid '
Following repetitive ECIB delivered over a period of 10 to 30 days
(accumulated dose 93,000 to 250,000 rads to erythrocytes), near
normal primary responses and normal secondary responses were elicited
despite the production of a sustained lymphocytopenia. In these studies
antigen was injected subcutaneously in areas where regional lymph
nodes are the most important sites for antibody responses. In view
84
of the studies of Roser and Ford it would be of interest to study
the effects of prolonged ECIB on antitoxin production when tetanus
toxoid is injected intravenously where the spleen rather than the
regional lymph nodes would be mainly concerned with antibody responses.
ECIB is being used in a number of institutions for clinical renal
45 48 74 93-95
transplant immunosuppression • » > ( however, no controlled
animal experiments have been conducted. Therefore, the influence of
ECIB on goat renal allografts was studied ' . The aim of these
studies is to evaluate the influence of ECIB alone and in combination
with standard immunosuppressive therapy on renal allograft survival.
To date three different schedules of ECIB have been studied. The
first schedule consisted of repetitive pregraft ECIB at a transit
-21-
dose of approximately 325 r.ids. About 90 blood volumes were irradiated
prior to grafting. Due to unusually high susceptibility of goat red
blood cells to hemolysis by irradiation, relatively little ECIB could
be given at this relatively high transit dose. To overcome this
problem, a second schedule of repetitive pregraft ECIB was employed
using a lower transit dose of approximately 45 rads. With this
schedule, it was possible to deliver repetitive pregraft irradiation
to about 200 blood volumes without inducing hemolysis. The third
schedule of ECIB was similar to the second with the exception that
repetitive postgraft ECIB (40 to 100 blood volumes) was added.
Controls consisted of one group which received no treatment and a
second group which received sham-ECIB with schedules similar to those
employed for ECIB-III. The results of these studies are shown
in Figure 7. Schedule III was most effective in prolonging the renal
allograft survival. The general conclusions from these studies are;
(1) the total number of blood volumes irradiated prior to grafting
may be important for ECIB induced immunosuppression and; (2) Pre- and
post graft ECIB is superior to pregraft ECIB only. It is worth
mentioning that these results were obtained in randomly matched recipient-
donor pairs and without the benefit of standard immunosuppressive drugs.
ECIB and azathioprine were shown to have a synergistic immunosuppressive
90
effect on skin allografts , and one might anticipate a similar effect
on renal allografts.
Clinical Studies
Results of trials with ECIB as an immunosuppressive agent in
prolonging the survival of renal transplants have been reported from
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a number of Institutions45'48'74'93"95'97. At only two of these
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centers ' has the number of patients subjected to IX1IJ been adequate
to allow critical comment. In their initial series, Weeke et al ,
reported the results in 11 patients who were subjected to pregraft
ECIB. In 10 of these recipients, the transplanted kidney was obtained
from a close relative. The 11th patient was subjected to two separate
sessions of ECIB prior to receiving a cadaver graft. Eight of the
recipients were also given variable amounts of postgraft ECIB. Post-
transplant drug therapy consisted of azathioprine and prednisone. It
is interesting to note that none of these patients received actlnomycin C.
Pronounced lymphocytopenia was induced in all patients and during post-
transplant period the average lymphocyte concentration remained below
507. of the pre-ECIB value. The authors state that the clinical course
in all instances was benign, with no irreversible rejection episodes
even though the dose of immunosuppressive drugs was small. In a more
97
recent publication, Weeke and Thaysen have described the influence
of ECIB on cadaveric kidney transplantation. This series consisted
of 91 recipients of which 37 received pre- and immediate postgraft
ECIB. The ECIB treated group suffered from a significantly reduced
number of acute rejection episodes and had a 25% better graft survival
during the first 6 months postgraft period. In addition the clinical
rank of the ECIB treated group was better during the first 6 months
of postgraft period. There was no increased incidence of severe
infections in ECIB treated group as compared to non-ECIB treated
group.
95
Persson ct al have published the results of renal transplantation
in 145 recipients, of which 27 were subjected to pregraft ECIB at a transit
-23-
dose of approximately 600 rads. Recipients treated by ECIB had fewer
and less severe acute rejection episodes. Renal function and graft
survival was better in the ECIB treated group as compared to the non-
ECIB treated group, although both groups received comfarable amounts
of chemotherapy.
Although lymphocytopenia was sustained in all patients subjected
95 97
to ECIB ' , there was no clear cut correlation between the degree
of lymphocytopenia and the iminunosuppressive effects of ECIB. ECIB
appears to have resulted in some benefit during the immediate postgraft
period. Results of long term followup with regard to graft and patient
survival are not yet available. In view of the many variables involved,
properly controlled, randomized clinical research studies are necessary
to evaluate the effectiveness of ECIB.
Influence of ECIB as an immunosuppressive agent in the treatment
of active, non-alcoholic cirrhosis with high serum ganmaglobulin levels
98
has been studied by Ranek et al . The results from 4 patients were
not encouraging.
Extracorporeal Irradiation of Lymph
Experimental Studies: Central and Regional Lymph
Under certain experimental conditions it is possible to consider
52
thoracic duct lymph as if it were regional lymph . It has been
demonstrated that skin allograft antigens reach the regional lymph
99
node via the afferent lymphatics , and there is ample evidence to
suggest that the immunologically committed lymphocytes emerge from
stimulated lymph nodes via efferent lymphatics and enter the blood
100,101
via contra! lymph • It has also been
•24-
suggested that metastatic activation of distant lymph nodes and the
spleen is via a similar route . It is possible to place skin
ailcgrafts on posterior part of the body from which all efferent
lymph enters the thoracic duct prior to its entry in to the blood
circulation. In this situation, all immunologically comnitted
lymphocytes from the regional lymph node can be subjected to
irradiation by ECIL. This approach should assure a complete block
of the efferent arc of the immune response and survival of the skin
allograft ("posterior grafts") for the duration of ECIL, provided
that there are no functional lymphatico-venous or lymphatico-
102
lymphatic communications . Under experimental conditions where
the kin allograft ("anterior grafts") are so placed that the
efferent lymph does not gain access to the blood circulation via
the thoracic duct, irradiation of thoracic duct lymphocytes would
be expected to only induce some degree of iramunosuppression by
depletion of recirculating lymphocytes including a fraction of the
recirculating specifically stimulated lymphocytes. Both these
50 52 59
approaches have been utilized ' . Continuous ECIL for 10 to
20 days prior to grafting resulted in a 5-8 day prolongation of the
survival time irrespective of the anatomical location of the skin
allograft. Combination of pre- and postgraft ECIB resulted in
further prolongation of the graft survival, but in this situation
52
"posterior grafts" survived for the duration of ECIL . The
observation that postgraft ECIL further extended the survival of
"anterior grafts" suggests that the specifically activated cells
do recirculate through the thoracic duct lymph.
-25-
In addition to the influence of ECIL on skin a Hograft survival,
cytotoxic antibody responses were also measured in recipients of
'anterior' and "posterior" skin allografts subjected to continuous
ECIB for up to 28 days . It is of interest that in calves, which
maintained "posterior" grafts until ECIL was discontinued, the
cytotoxic antibody response was markedly depressed. Following the
termination of ECIL, cytotoxicity of the sera increased presumably
the result of specifically stimulated lymphocytes entering the circulation
via the thoracic duct. Surgical removal of the grafts prior to rejection
indicated that the rejection per se was not necessary for the rise in
cytotoxic activity.
Clinical Studies
Despite the encouraging results thus far obtained from experimental
studies, there has been no adequate trial of ECIL for immunosuppression
in man. Both the results of experimental studies as discussed above
and the immunosuppressive effects of thoracic duct lymphocyte depletion
by techniques other than ECIL ' suggest a useful potential role
of ECIL for clinical immunosuppression.
CONCLUDING REMARKS
Of all the techniques investigated for selective immunosuppression
by radiation, as discussed in this and a previous review only ECIB,
ECIL and graft irradiation havs potential for clinical application.
ECIB and graft radiation have actually been applied for immunosuppression
in man. The experimental exploitations of other techniques have,
however, contributed a great deal of information towards a better
understanding of the role of the lymphocyte in the immune response.
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Despttc the proven usefulness of ECIB as an adjunct lmmunosupprcsslve
regimen, the best ECIB schedule and transit dose remain unsettled in
man . Currently available data Indicate that repetitive pre- and
postgraft sessions of ECIB at a relatively high transit dose (~ 300
to 500 rads) can be expected to yield the best results in prolonging
allograft survival. Even with well planned schedules of ECIB, the
dose accumulated by erythrocytes would restrict the duration of
postgraft ECIB. In addition, repetitive non-continuous sessions
would not permit irradiation of all long-lived recirculating
and newly formed lymphocytes entering and leaving the blood between
ECIB sessions. A majority of the long-lived, recirculating lymphocytes
are thymus-derived. In addition, the blood contains many newly-formed
thymus-derived, histocompatibility antigen reactive lymphocytes which
41
do not enter the recirculating pool . The blood transit time of
these newly-formed lymphocytes is not known. It is conceivable that
a majority of these newly formed lymphocytes enter and-exit the blood




as described for the rat , uggested in the calf by the studies
on thymus cell migration
Continuous ECIB reduces the blood and thoracic duct lymphocyte
21
counts to about 20% of the control values within 12 hours « This
initial depletion of an easily mobili.zable pool of lymphocytes is
followed by a period of longer duration during which the number of
lymphocytes in various compartments is reduced much more slowly. This
latter pool is comprised of relatively sessile and some newly produced
-27- •
lymphocytes. Continuous EC1L results In a two-component decrease in
»
the output of thoracic duct lymphocytes . The first component, corres-
ponds to the elimination of the easily mobilizable pool and has a half
time of about 1.2 days. The second component with a half time of
approximately 30 days represents the relatively sessile pool. Extracorporeal
irradiation alone, for all practical purposes, is an inadequate procedure
for the depletion of this relatively sessile pool , which contains immuno-
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competent cells . Agents capable of mobilizing the sessile pool with
resultant lymphocytosis should improve the effectiveness of extracorporeal
irradiation
The effectiveness of a particular transit dose has only been
assessed by the degree and duration of lymphocytopenia induced following
8,111,112
ECIB ' . Such a measurement fails to consider the radiosensitivity
of various functional subpopulations of lymphocytes in the circulation
It is thus not surprising that the level of immunosuppression achieved
by ECIB has not shown any definite correlation with the degree of
lymphocytopenia ' . In future studies, the functional evaluation of
subpopulations of circulating lymphocytes during and following
extracorporeal irradiation are essential.
The influence of ECIB on circulating stem cells in the blood
has not been determined. This question does not arise with ECIL as the
lymph does not contain stem cells . In view of the obvious
implications of possible stem cell damage and depletion by ECIB, such
studies are necessary. The technique for stem cell determination
in the mouse is the spleen colony forming assay , unfortunately, this




In agar assays the granulocyte and macrophage progenitors . It
has been claimed, however, that in dog the number of colony forming
units in agar in the peripheral blood is an indicator of the
presence of pluipotent hemopoietic stem cells as measured by the
in vivo bone marrow repopulation of dogs subjected to 1200 rad WBR
9
and infused with 3 to 40 x 10 autologous or allogeneic mononuclear
blood cells.(T. M. Fliedner; personal, communication). Colony formation
in agar might therefore be a suitable technique for application
during and following ECIB in man.
In view of the paucity of erythrocytes in the thoracic duct lymph,
the restriction imposed by ECIB are fortunately not applicable to ECIL.
The best ECIL schedule therefore would appear to be continuous pre- and
postgraft irradiation at a high transit dose (~ 1,000 rads). In practice, •
however, it would be impossible to continue ECIL indefinitely. This may,
however, not be necessary. One might be able to discontinue ECIL at some
stage following allografting without jeopardizing the allograft. Hall
has reported that in efferent lymph from regional lymph nodes, the numbers
of basophilic cells decrease markedly by 20th day postgrafting . Moreover
non-specific factors such as the graft adaptation might also result in
reduced immunological reactivity .
These considerations would lead one to believe that the ideal
schedule of extracorporeal irradiation for maximum iimnunosuppressive
activity would be repetitive daily ECIB combined with continuous ECIL.
-29-
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Fig. 1 A schematic reprcscnt.ition of extracorporcal irradiation
of blood (F.CIB) in goats.
Fig. 2 The relationship of the number of blood volumes irradiated
during ECIB to the percent of circulating blood elements
(present in circulating blood during the course of ECIB)
receiving no radiation. This curve was generated from
data obtained in patients and calculated according to the
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formula of Marsaglia and Thomas . (The authors thank Dr.
J. S. Robertson for help in preparation of this figure).
Fig. 3 The in-vivo radiosensitivity of lymphocytes as reported by
Trowell . The three arrows and bold horizontal lines
indicate the expected lymphocyte survival, according to
Trowell's data, at different transit doses. The top,
middle and lower arrows correspond to doses of ~ 30 rads,
~ 500 rads and ~ 1,000 rads respectively. The middle
(~*500 rads) and lower (~ 1000 rads) arrows represent the
usual transit doses employed by us for ECIB and ECIL
respectively.
Fig. 4 The influence of low (~ 30 rads) and high transit dose
(~ 1000 rads) extracorporeal irradiation of lymph (ECIL)
on thoracic duct (TD) lymphocyte output in the calf.
Fig. 5 The influence of repetitive ECIB on blood lymphocyte
levels (transit dose ~ 800 rads) in adrenalectomized and
sham-adrenalectomizcd calves. Each calf was given ten
sessions of ECIB with nn equivalent of 5 blood volumes
per session.
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F i g . 6 'flu1 inf liu-nci1 of con t i nuous iiCIL in one ndi i-na lit .tomi zi-d ami
one shani-adrrna 1eclomizcd c a l f on tin- output of I h o n u i i
duct (I'D) lymphocytes . A t r a n s i t dost- of a p p r o x i m a t e l y
1,000 rads was employed.
Fig. 7 Survival of bilaterally nephrectomized goats receiving
renal allografts. The mean and range of recipient survival
is shown for various treatment groups. The details of
ECIL and sham-ECIB schedules are provided in the text.
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